Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial.
about
Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@ast
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@en
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@nl
type
label
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@ast
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@en
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@nl
prefLabel
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@ast
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@en
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@nl
P2093
P2860
P356
P1476
Safety and immunogenicity of h ...... to 45 years: a phase I trial.
@en
P2093
Chang-Gui Li
Feng-Cai Zhu
Hai-Wen Tang
Hong-Xing Pan
Sanjoy Datta
Yi-Ju Zhang
P2860
P304
P356
10.5732/CJC.010.10564
P577
2011-08-01T00:00:00Z